SEHK:911

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Qianhai Health Holdings

Executive Summary

Qianhai Health Holdings Limited, an investment holding company, engages in the sale of health products in Hong Kong.


Snowflake Analysis

Excellent balance sheet and fair value.

Share Price & News

How has Qianhai Health Holdings's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 911's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

-10.1%

911

-1.3%

HK Retail Distributors

-3.1%

HK Market


1 Year Return

-48.5%

911

-21.5%

HK Retail Distributors

-9.9%

HK Market

Return vs Industry: 911 underperformed the Hong Kong Retail Distributors industry which returned -21.5% over the past year.

Return vs Market: 911 underperformed the Hong Kong Market which returned -9.9% over the past year.


Shareholder returns

911IndustryMarket
7 Day-10.1%-1.3%-3.1%
30 Day-14.5%-1.5%0.4%
90 Day-37.1%-11.6%-8.0%
1 Year-48.5%-48.5%-20.8%-21.5%-6.9%-9.9%
3 Year-86.6%-86.8%-37.4%-40.6%-3.9%-13.7%
5 Year-99.6%-99.6%-64.2%-66.8%-16.1%-29.1%

Price Volatility Vs. Market

How volatile is Qianhai Health Holdings's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Qianhai Health Holdings undervalued compared to its fair value and its price relative to the market?

7.86x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate 911's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate 911's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: 911 is good value based on its PE Ratio (7.9x) compared to the Retail Distributors industry average (8.3x).

PE vs Market: 911 is good value based on its PE Ratio (7.9x) compared to the Hong Kong market (9.4x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 911's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 911 is good value based on its PB Ratio (0.3x) compared to the HK Retail Distributors industry average (0.7x).


Next Steps

Future Growth

How is Qianhai Health Holdings forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

4.0%

Forecasted Retail industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Qianhai Health Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Qianhai Health Holdings performed over the past 5 years?

11.2%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 911 has a high level of non-cash earnings.

Growing Profit Margin: 911's current net profit margins (4.5%) are lower than last year (6.5%).


Past Earnings Growth Analysis

Earnings Trend: 911 has become profitable over the past 5 years, growing earnings by 11.2% per year.

Accelerating Growth: 911's earnings growth over the past year (426.8%) exceeds its 5-year average (11.2% per year).

Earnings vs Industry: 911 earnings growth over the past year (426.8%) exceeded the Retail Distributors industry 0.6%.


Return on Equity

High ROE: 911's Return on Equity (4%) is considered low.


Next Steps

Financial Health

How is Qianhai Health Holdings's financial position?


Financial Position Analysis

Short Term Liabilities: 911's short term assets (HK$508.9M) exceed its short term liabilities (HK$122.8M).

Long Term Liabilities: 911's short term assets (HK$508.9M) exceed its long term liabilities (HK$859.0K).


Debt to Equity History and Analysis

Debt Level: 911's debt to equity ratio (11.3%) is considered satisfactory.

Reducing Debt: 911's debt to equity ratio has reduced from 150.7% to 11.3% over the past 5 years.

Debt Coverage: 911's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: 911 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Next Steps

Dividend

What is Qianhai Health Holdings's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate 911's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate 911's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if 911's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 911's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: 911 is not paying a notable dividend for the Hong Kong market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of 911's dividend in 3 years as they are not forecast to pay a notable one for the Hong Kong market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.1yrs

Average board tenure


CEO

Qianhai Health Holdings has no CEO, or we have no data on them.


Board Members

NamePositionTenureCompensationOwnership
Hin Chi Lam
Group CFO & Executive Director0.83yrHK$791.00kno data
Keli Xu
Executive Director0.83yrHK$512.00k0.56% HK$1.2m
Wai Leung Wu
Independent Non-Executive Director4.25yrsHK$180.00kno data
Chee Lap Yuen
Independent Non-Executive Director4.25yrsHK$180.00kno data
Wei Li
Independent Non-Executive Director4yrsHK$180.00kno data
Tzea Lim
Non-Executive Director1.08yrsHK$140.00kno data
Guanchao Huang
Non-Executive Chairman1yrno datano data

1.1yrs

Average Tenure

51yo

Average Age

Experienced Board: 911's board of directors are not considered experienced ( 1.1 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Qianhai Health Holdings Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Qianhai Health Holdings Limited
  • Ticker: 911
  • Exchange: SEHK
  • Founded: 1989
  • Industry: Distributors
  • Sector: Retail
  • Market Cap: HK$209.902m
  • Shares outstanding: 1.69b
  • Website: https://www.qianhaihealth.com.hk

Number of Employees


Location

  • Qianhai Health Holdings Limited
  • Wing Tuck Commercial Centre
  • Room 301-303
  • Sheung Wan
  • Hong Kong

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
911SEHK (The Stock Exchange of Hong Kong Ltd.)YesOrdinary SharesHKHKDJun 2014
911SEHK (The Stock Exchange of Hong Kong Ltd.)HKD0.04HKHKDSep 2018

Biography

Qianhai Health Holdings Limited, an investment holding company, engages in the sale of health products in Hong Kong. It operates through Health-Care Products and Electronic Component Products segments. The company offers Chinese herbal medicines, and skin-care and other health-care products to wholesalers and retailers. It offers American ginseng, an herbaceous perennial plant, which includes cultivated and wild ginseng; and ginseng wine. The company is also involved in the sale of information technology components, such as central processing units and semi-conductors. In addition, it engages in the property and other assets holding, and property leasing activities; and money lending business through the provision of secured and unsecured loans. The company was formerly known as Hang Fat Ginseng Holdings Company Limited and changed its name to Qianhai Health Holdings Limited in September 2016. The company was founded in 1989 and is based in Sheung Wan, Hong Kong. Qianhai Health Holdings Limited is a subsidiary of Explorer Rosy Limited. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/05/27 13:31
End of Day Share Price2020/05/27 00:00
Earnings2019/12/31
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.